UPDATE 3-GE chief Culp sells biopharma business for $21.4 bln
February 25, 2019 at 09:21 AM EST
Shares of General Electric Co surged 15 percent on Monday after the industrial conglomerate said it would sell its biopharma business to Danaher Corp for $21.4 billion, its first major asset sale under new Chief Executive Officer Larry Culp.
